Supplementary Data for Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencypron
Characteristics and clinical baseline parameters of melanoma patients in the study.</p
Drug-induced toxic epidermal necrolysis (TEN) is a rare but potentially lethal bullous disease whose...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
Abstract Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment...
Formalin‐fixed paraffin embedded (FFPE) clinical tissues represent an abundant and unique resource f...
Currently clinical outcome in melanoma is not predictable by known serum biomarkers. The only reliab...
Differentially expressed proteins (DEPs) and functional annotation of NR proteomes based on GO term ...
Purpose. Melanoma is the most aggressive cutaneous cancer without effective treatment. Diagnosis is ...
Antibodies used for immunofluorescence staining on a melanoma tissue microarray (TMA).</p
Malignant melanoma has the highest increase of incidence of malignancies in the western world. In ea...
Differentially expressed proteins (DEPs) in NR of the discovery serum and tumor cell cohorts.</p
Cutaneous melanoma is a malignant tumor of skin melanocytes that are pigment-producing cells located...
BACKGROUND: Blood-based proteomic profiling may aid and expand our understanding of diseases and the...
Melanoma is a skin cancer with permanently increasing incidence and resistance to therapies in advan...
Copyright: © 2012 Byrum SD, et al. This is an open-access article distributed under the terms of th...
Characteristics and clinical baseline parameters of melanoma patients in the study.</p
Drug-induced toxic epidermal necrolysis (TEN) is a rare but potentially lethal bullous disease whose...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
Abstract Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment...
Formalin‐fixed paraffin embedded (FFPE) clinical tissues represent an abundant and unique resource f...
Currently clinical outcome in melanoma is not predictable by known serum biomarkers. The only reliab...
Differentially expressed proteins (DEPs) and functional annotation of NR proteomes based on GO term ...
Purpose. Melanoma is the most aggressive cutaneous cancer without effective treatment. Diagnosis is ...
Antibodies used for immunofluorescence staining on a melanoma tissue microarray (TMA).</p
Malignant melanoma has the highest increase of incidence of malignancies in the western world. In ea...
Differentially expressed proteins (DEPs) in NR of the discovery serum and tumor cell cohorts.</p
Cutaneous melanoma is a malignant tumor of skin melanocytes that are pigment-producing cells located...
BACKGROUND: Blood-based proteomic profiling may aid and expand our understanding of diseases and the...
Melanoma is a skin cancer with permanently increasing incidence and resistance to therapies in advan...
Copyright: © 2012 Byrum SD, et al. This is an open-access article distributed under the terms of th...
Characteristics and clinical baseline parameters of melanoma patients in the study.</p
Drug-induced toxic epidermal necrolysis (TEN) is a rare but potentially lethal bullous disease whose...
Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neit...
DOI
Add to ORKG